Recall Record

Warren, NJ, United States

Glaxosmithkline Consumer Healthcare Holdings recalls

6 recalls recorded since 2018, most recently on 2 December 2022. None are listed as ongoing. Status and classification are as published by the FDA.

Recalls6
Ongoing (FDA)0
Terminated or completed6
Class I (FDA)0

Completed Class II Drugs

Recall started
2 December 2022
Reason
Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.
Distribution
Nationwide within the United States
Initiated
Voluntary: Firm initiated
Recall numbers
D-0076-2024, D-0073-2024, D-0079-2024, D-0074-2024, D-0075-2024, D-0078-2024, D-0077-2024

Terminated Class II Drugs

Recall started
16 June 2020
Terminated
3 June 2022
Reason
Defective Delivery System: the dosing cups are missing graduations applicable to certain age groups.
Distribution
Nationwide in the US
Initiated
Voluntary: Firm initiated
Recall numbers
D-1362-2020, D-1361-2020

Terminated Class II Drugs

Recall started
28 May 2020
Terminated
24 January 2022
Reason
Labeling: Label lacks warning - Magnesium safety warning is not present on the Gaviscon bottle label.
Distribution
U.S.A. Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
D-1323-2020, D-1324-2020, D-1325-2020, D-1322-2020

Terminated Class II Food

Recall started
28 April 2020
Terminated
1 June 2021
Reason
Fiber prebiotic product potentially contaminated with small plastic pieces
Distribution
Distributed to the following US states: AR, CA, FL, HI, ID, IL, LA, MA, ME, MI, MN, MO, NC, NE, NJ, NY, OH, OR, PA, RI, SC, TX, VA, WA, and WI
Initiated
Voluntary: Firm initiated
Recall numbers
F-0950-2020, F-0951-2020

Terminated Class III Drugs

Recall started
20 April 2020
Terminated
26 October 2021
Reason
Labeling: Not elsewhere classified: Observed separation in the secondary packaging in the blister and the backer card
Distribution
Nationwide
Initiated
Voluntary: Firm initiated
Recall numbers
D-1267-2020, D-1268-2020, D-1266-2020

Terminated Class II Drugs

Recall started
16 March 2020
Terminated
28 October 2021
Reason
Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.
Distribution
Product was distributed throughout the United States, including Puerto Rico.
Initiated
Voluntary: Firm initiated
Recall numbers
D-1066-2020, D-1065-2020, D-1068-2020, D-1069-2020, D-1067-2020

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.